We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

1 hedge funds and large institutions have $3K invested in GW Pharmaceuticals Plc American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 294 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 2971 (-296)

100% less funds holding in top 10

Funds holding in top 10: 210 (-21)

100% less capital invested

Capital invested by funds: $5.23B → $3K (-$5.23B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 294

Holders
1
Holders Change
-296
Holders Change %
-99.66%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
-21
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
294
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
HDIM
1
Hanson & Doremus Investment Management
Vermont
$3K
PCM
2
Pentwater Capital Management
Florida
-$456M -2,102,104 Closed
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
-$325M -1,500,000 Closed
HI
4
HBK Investments
Texas
-$292M -1,348,216 Closed
FCM
5
Farallon Capital Management
California
-$277M -1,278,900 Closed
GCL
6
Glazer Capital LLC
New York
-$212M -978,045 Closed
EMG
7
ETF Managers Group
New Jersey
-$187M -862,727 Closed
AAM
8
Alpine Associates Management
Florida
-$171M -787,500 Closed
UOC
9
UBS O'Connor
Illinois
-$170M -785,841 Closed
Millennium Management
10
Millennium Management
New York
-$165M -762,640 Closed
Morgan Stanley
11
Morgan Stanley
New York
-$142M -653,789 Closed
Bank of America
12
Bank of America
North Carolina
-$139M -641,796 Closed
MF
13
Magnetar Financial
Illinois
-$125M -577,789 Closed
TAL
14
TIG Advisors LLC
New York
-$124M -572,743 Closed
Balyasny Asset Management
15
Balyasny Asset Management
Illinois
-$99.3M -457,697 Closed
Janus Henderson Group
16
Janus Henderson Group
United Kingdom
-$98.6M -454,725 Closed
BCM
17
Brown Capital Management
Maryland
-$98.2M -452,783 Closed
JP Morgan Chase
18
JP Morgan Chase
New York
-$83.7M -385,738 Closed
SCC
19
Spring Creek Capital
Kansas
-$80.3M -370,000 Closed
Renaissance Technologies
20
Renaissance Technologies
New York
-$76.4M -352,100 Closed
Grantham, Mayo, Van Otterloo & Co (GMO)
21
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
-$72.6M -334,864 Closed
CC
22
Carlson Capital
Texas
-$71.6M -330,173 Closed
SCM
23
Segantii Capital Management
Hong Kong
-$66.5M -306,408 Closed
Capital World Investors
24
Capital World Investors
California
-$60.9M -280,774 Closed
DAM
25
DLD Asset Management
New York
-$60.7M -280,000 Closed

GWPH Hedge Fund Activity: Q2 2021 in Review

1 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2021, worth a combined $3K — down 100% from $5.23B a quarter earlier.

Sellers outnumbered buyers: 294 funds closed out of GWPH and 0 opened new positions — a net loss of 294 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Pentwater Capital Management, exiting entirely with an estimated $456M sold.

  • 1 institutional investor held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2021, down from 297 in Q1 2021.
  • Funds reported $3K of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2021 and 294 closed out, a net change of -294 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q2 2021 was Pentwater Capital Management, an estimated $456M sold.

Based on aggregated 13F filings for Q2 2021.